全文获取类型
收费全文 | 29030篇 |
免费 | 1701篇 |
国内免费 | 1316篇 |
专业分类
耳鼻咽喉 | 163篇 |
儿科学 | 190篇 |
妇产科学 | 372篇 |
基础医学 | 2533篇 |
口腔科学 | 886篇 |
临床医学 | 2551篇 |
内科学 | 3531篇 |
皮肤病学 | 336篇 |
神经病学 | 767篇 |
特种医学 | 894篇 |
外国民族医学 | 5篇 |
外科学 | 1972篇 |
综合类 | 7327篇 |
现状与发展 | 3篇 |
一般理论 | 1篇 |
预防医学 | 2346篇 |
眼科学 | 637篇 |
药学 | 2531篇 |
2篇 | |
中国医学 | 3139篇 |
肿瘤学 | 1861篇 |
出版年
2024年 | 31篇 |
2023年 | 190篇 |
2022年 | 379篇 |
2021年 | 588篇 |
2020年 | 429篇 |
2019年 | 381篇 |
2018年 | 420篇 |
2017年 | 407篇 |
2016年 | 380篇 |
2015年 | 571篇 |
2014年 | 702篇 |
2013年 | 700篇 |
2012年 | 1122篇 |
2011年 | 2034篇 |
2010年 | 1310篇 |
2009年 | 930篇 |
2008年 | 1175篇 |
2007年 | 1101篇 |
2006年 | 1085篇 |
2005年 | 1486篇 |
2004年 | 2882篇 |
2003年 | 2516篇 |
2002年 | 2009篇 |
2001年 | 1693篇 |
2000年 | 1077篇 |
1999年 | 1101篇 |
1998年 | 753篇 |
1997年 | 715篇 |
1996年 | 416篇 |
1995年 | 361篇 |
1994年 | 436篇 |
1993年 | 590篇 |
1992年 | 521篇 |
1991年 | 420篇 |
1990年 | 213篇 |
1989年 | 191篇 |
1988年 | 156篇 |
1987年 | 147篇 |
1986年 | 149篇 |
1985年 | 120篇 |
1984年 | 61篇 |
1983年 | 23篇 |
1982年 | 16篇 |
1981年 | 9篇 |
1979年 | 8篇 |
1978年 | 5篇 |
1977年 | 6篇 |
1975年 | 4篇 |
1974年 | 5篇 |
1965年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
人工智能(Artificial Intelligence,AI)的蓬勃兴起为现代社会带来了前所未有的机遇,中医药是中华民族传承千年的文化瑰宝。随着人工智能技术不断在中医药领域的科技创新中崭露头角,二者的融合不断加深,人工智能在中医药领域的发展前景、争议挑战也引发了诸多思考。本文将从人工智能在中医药领域的应用入手,对人工智能辅助中医诊断、智能决策与数据挖掘、健康管理及中草药现代化研究等方面,就近年来国内外研究进展进行总结与分析,以期为AI视域下实现中医药现代化、智能化赋能。 相似文献
2.
3.
4.
5.
目的 探讨阿戈美拉汀联合乙哌立松治疗青年慢性紧张性头痛(Chronictention-typeheadache,CTTH)的疗效及安全性.方法 80例青年慢性紧张性头痛患者依据是否倒班随机分为对照组和治疗组,对照组口服乙哌立松治疗,治疗组在对照组基础上联合阿戈美拉汀治疗,评估2组患者治疗前匹兹堡睡眠量表评分(PSQI)评估治疗6周后两组的头痛疗效以及不良反应.结果 倒班人员的入组前PSQI的总评分、睡眠质量、入睡时间、催眠药物及睡眠障碍因子分高于非倒班人员;治疗组的疗效优于对照组,有统计学意义(P<0.05);治疗组内,倒班患者疗效优于非倒班患者(P<0.05).两组不良反应无明显差异.结论 阿戈美拉汀联合乙哌立松治疗慢性紧张性头痛的的疗效确切,安全性高. 相似文献
6.
7.
Zheyuan Wang Zhiheng Shi Lu Zhang Huihan Zhang Yawu Zhang 《Pathology, research and practice》2019,215(3):499-505
Profilin 1 (PFN1) is a critical actin-regulatory protein; however, its functional role in hepatocellular carcinoma (HCC) progression remains to be further elucidated. In the present study, we observed that the expression levels of PFN1 were significantly decreased in HCC tissues and cell lines. Low PFN1 expression was significantly correlated with aggressive clinicopathological characteristics and poor prognosis of HCC patients. Further in vitro experiments demonstrated that overexpression of PFN1 remarkably inhibited the proliferation, migration, invasion and EMT of HCC cells. Moreover, we also found that PFN1 was a direct target gene of miR-19a-3p, and in HCC tissues, and there was a significantly inverse correlation between PFN1 mRNA and miR-19a-3p expression. Collectively, our results showed that PFN1 functions as a tumor suppressor in HCC, and might serve as a diagnostic and therapeutic target for HCC patients. 相似文献
8.
9.
10.
Multidisciplinary predialysis education and team care (MDC) may slow the decline in renal function in patients with chronic kidney disease (CKD). However, associations between unexpected return during MDC and progression of renal dysfunction have not been characterized in patients with CKD. Our study aimed to determine the association between exacerbation of renal dysfunction and the frequency of unexpected return during follow-up.A total of 437 patients with CKD receiving multidisciplinary care between January 2009 and June 2013 at the Shin-Kong Wu Ho-Su Memorial Hospital were included in this retrospective observational cohort study, and multiple imputations were performed for missing data. The predictor was the frequency of unexpected return for follow-up during the first year after entering MDC. Main outcome was monthly declines in estimated glomerular filtration rates (eGFR). Moreover, the demographic data, comorbidities, history of medication, and routine laboratory data for patients with CKD were collected.Among all patients, 59.7% were male, the mean age at initiation of MDC was 69.4 ± 13.2 years, and the duration of follow-up was 21.4 ± 3.3 months. The subjects were divided into 2 groups according to frequencies of follow-up (≤4 and > 4 visits) during the 1st year of MDC. The patients with CKD were regularly followed up every 3 months as a part of MDC in our hospital, and patients who returned for more than 4 follow-up visits were included in the unexpected return group. In crude regression analyses, unexpected return was significantly associated with higher monthly declines of eGFR (β = 0.092, 95% confidence interval, 0.014–0.170). This association remained after adjustments for multiple variables, and subgroup analyses of unexpected return showed that male gender, older age, CKD stage 1 to 3, hypertension, history of coronary artery disease, and use of renin–angiotensin system blockade were significantly associated with declines in renal function.In conclusion, unexpected return for follow-up during the 1st year of MDC was significantly associated with the deterioration of renal function. 相似文献